Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alloway

Showing results (321-330 of 360) with videos related to

Pageof 36
Sort By:
Surgery|October 17, 2001
Renal allograft outcomes in African American versus Caucasian transplant recipients in the tacrolimus eraK L Hardinger, R J Stratta, M F Egidi, et al.
Kidney International Reports|March 23, 2019
Impact of Induction Therapy on Circulating T Follicular Helper Cells and Subsequent Donor-Specific Antibody Formation After Kidney TransplantCamila Macedo, Kevin Hadi, John Walters, et al.
Clinical Transplantation|October 10, 2002
Thymoglobulin for induction or rejection therapy in pancreas allograft recipients: a single centre experienceJennifer Trofe, Robert J Stratta, M Francesca Egidi, et al.
Clinical Transplantation|November 16, 2017
A phase Ib, open-label, single arm study to assess the safety, pharmacokinetics, and impact on humoral sensitization of SANGUINATE infusion in patients with end-stage renal diseaseBassam G Abu Jawdeh, Ervin Steve Woodle, Abbie D Leino, et al.
Clinical Transplantation|March 26, 2017
Pharmacokinetic and pharmacogenetic analysis of immunosuppressive agents after laparoscopic sleeve gastrectomyTayyab S Diwan, Alicia B Lichvar, Abbie D Leino, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 10, 2019
Proteasomal adaptations underlying carfilzomib-resistance in human bone marrow plasma cellsE Steve Woodle, Simon Tremblay, Paul Brailey, et al.
Transplantation Proceedings|April 26, 2005
Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapyC C Rogers, M Hanaway, R R Alloway, et al.
Transplantation|May 28, 2011
Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibitionR Carlin Walsh, Paul Brailey, Alin Girnita, et al.
Transplantation|June 26, 2007
Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipientsSander Florman, Rita Alloway, Munci Kalayoglu, et al.
Clinical Transplantation|May 20, 2019
Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor poolAnn Dao, Madison Cuffy, Tiffany E Kaiser, et al.
Pageof 36

Showing results (321-330 of 360) with videos related to

Sort By:
Pageof 36
Surgery|October 17, 2001
Renal allograft outcomes in African American versus Caucasian transplant recipients in the tacrolimus eraK L Hardinger, R J Stratta, M F Egidi, et al.
Kidney International Reports|March 23, 2019
Impact of Induction Therapy on Circulating T Follicular Helper Cells and Subsequent Donor-Specific Antibody Formation After Kidney TransplantCamila Macedo, Kevin Hadi, John Walters, et al.
Clinical Transplantation|October 10, 2002
Thymoglobulin for induction or rejection therapy in pancreas allograft recipients: a single centre experienceJennifer Trofe, Robert J Stratta, M Francesca Egidi, et al.
Clinical Transplantation|November 16, 2017
A phase Ib, open-label, single arm study to assess the safety, pharmacokinetics, and impact on humoral sensitization of SANGUINATE infusion in patients with end-stage renal diseaseBassam G Abu Jawdeh, Ervin Steve Woodle, Abbie D Leino, et al.
Clinical Transplantation|March 26, 2017
Pharmacokinetic and pharmacogenetic analysis of immunosuppressive agents after laparoscopic sleeve gastrectomyTayyab S Diwan, Alicia B Lichvar, Abbie D Leino, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 10, 2019
Proteasomal adaptations underlying carfilzomib-resistance in human bone marrow plasma cellsE Steve Woodle, Simon Tremblay, Paul Brailey, et al.
Transplantation Proceedings|April 26, 2005
Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapyC C Rogers, M Hanaway, R R Alloway, et al.
Transplantation|May 28, 2011
Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibitionR Carlin Walsh, Paul Brailey, Alin Girnita, et al.
Transplantation|June 26, 2007
Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipientsSander Florman, Rita Alloway, Munci Kalayoglu, et al.
Clinical Transplantation|May 20, 2019
Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor poolAnn Dao, Madison Cuffy, Tiffany E Kaiser, et al.
Pageof 36